Literature DB >> 17707008

Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia.

Dix P Poppas1, Ariella A Hochsztein, Rebecca N Baergen, Emily Loyd, Jie Chen, Diane Felsen.   

Abstract

PURPOSE: Masculinization of the female genitalia observed in patients with classic congenital adrenal hyperplasia often results in clitorimegaly. Reduction clitoroplasty is the most widely practiced corrective surgery for clitorimegaly, yet reservations about surgical intervention exist based on fears of nerve destruction during surgical removal of excess erectile tissue. In this study, we modified the reduction clitoroplasty and examined excised erectile tissue for the presence of dorsal nerves.
MATERIALS AND METHODS: We describe the development of the nerve sparing ventral clitoroplasty. Nerves were examined in situ using optical coherence technology. In addition, erectile tissue removed from 27 female patients with congenital adrenal hyperplasia was examined immunohistochemically for the presence of nerves by staining for neurofilament. Nerves outside of the tunica albuginea were counted and measured. Tissue from 2 adult females was also examined by immunohistochemistry.
RESULTS: Optical coherence technology visualized dorsal nerves in 3 patients with congenital adrenal hyperplasia (size 600 to 800 microm). In 4 of 27 patients undergoing nerve sparing ventral clitoroplasty, no dorsal nerve branches were visualized in excised erectile tissue. In another 18 patients 10 or fewer nerve branches were found. In patients who underwent nerve sparing ventral clitoroplasty 92% of dorsal nerves detected were 90 microm or less. In contrast, 88% of dorsal nerves found in the 2 adult specimens were 120 microm or greater. The maximum nerve fiber size observed in patient specimens was significantly smaller than the maximum nerve fiber size observed in control specimens.
CONCLUSIONS: Scarcity of large dorsal nerves in histological specimens excised using nerve sparing ventral clitoroplasty likely reflects their preservation within the congenital adrenal hyperplasia patients. This preservation is vital to future somatosensory and motor function of the clitoris.

Entities:  

Mesh:

Year:  2007        PMID: 17707008     DOI: 10.1016/j.juro.2007.03.186

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography.

Authors:  Berrend G Muller; Daniel M de Bruin; Willemien van den Bos; Martin J Brandt; Juliette F Velu; Mieke T J Bus; Dirk J Faber; Dilara Savci; Patricia J Zondervan; Theo M de Reijke; Pilar Laguna Pes; Jean de la Rosette; Ton G van Leeuwen
Journal:  J Med Imaging (Bellingham)       Date:  2015-07-09

2.  An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Traci L Schaeffer; Jeanie B Tryggestad; Ashwini Mallappa; Adam E Hanna; Sowmya Krishnan; Steven D Chernausek; Laura J Chalmers; William G Reiner; Brad P Kropp; Amy B Wisniewski
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-18

Review 3.  Gender dysphoria associated with disorders of sex development.

Authors:  Paulo Sampaio Furtado; Felipe Moraes; Renata Lago; Luciana Oliveira Barros; Maria Betânia Toralles; Ubirajara Barroso
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

Review 4.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

Review 5.  Congenital Adrenal Hyperplasia: Review from a Surgeon's Perspective in the Beginning of the Twenty-First Century.

Authors:  Lisandro Ariel Piaggio
Journal:  Front Pediatr       Date:  2014-01-02       Impact factor: 3.418

Review 6.  Treatment of the Enlarged Clitoris.

Authors:  Martin Kaefer; Richard C Rink
Journal:  Front Pediatr       Date:  2017-08-28       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.